VENMAX logo

Venmax Drugs & Pharmaceuticals Ltd

VENMAX·BSE·
14.20 +0.08 (+0.57%)
Market Cap12.23 Cr
PE Ratio83.40
Volume12,036
Day High - Low15.30 - 13.60
52W High-Low31.49 - 13.52
DocStoX Score
2.4/10
Poor
Fair Value
Sign in to see
ROE
2.70%
Weak
P/E
83.40x
Expensive
Debt / Equity
0.02
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

Day13.60
15.30
52W13.52
31.49
DocStoX take

Held back by momentum (0.0).

DocStoX score

Low confidence
2.4
/10
Poor
Quality
Weak
ROE 2.7%
Valuation
Expensive
P/E 83.4×
Growth
Slow
Revenue +116.1% 5Y CAGR
Risk
Moderate
D/E 0.02
Momentum
Weak
4% of 52-week range

At a glance

Market Cap
₹12 Cr
52W High / Low
₹31 / ₹14
Dividend Yield
0.00%
Promoter Holding
10.46%
EPS (TTM)
₹0.17
Book Value
₹14.37

Key highlights

  • Revenue compounding 116% a year
  • Low leverage — D/E 0.02
  • Quality is weak (1.7/10)
  • Valuation is weak (1.2/10)
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Venmax Drugs & Pharmaceuticals Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.